• Facebook
  • Twitter

Cheap Stock Of The Day

Altimmune, Inc. (Nasdaq: ALT), a clinical-stage immunotherapeutics company, recently announced additional positive data from a Phase 2 extension study of its NasoVAX intranasal influenza vaccine candidate. Data from this study demonstrated that 100% of the evaluated subjects remained seroprotected, and the seroconversion rate was unchanged more...

Boxlight Corporation (Nasdaq: BOXL) a leading provider of interactive technology solutions for the global education market, recently announced the company's financial results for the fourth quarter of 2018. Mark Elliott, Boxlight’s Chief Executive Officer, shared encouraging words: “We had an extremely eventful and productive 2018, particularly...